News Sentiment

002399 sentiment intelligence

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 2 relevant articles
Exchange SHZ China
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 9.78 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

75/100 classification confidence.

Company focus 2

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+2.5% over one week, +11.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

China's Hepalink invests $60M with TPG Biotechnology fund

Market Reaction

Balanced read

56/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 75/100 classification
One-week reaction 2.5% Price confirming higher
Trend fit Trend inactive 11.5% over four weeks
Fair value -9.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 2
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 2
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Fierce Pharma 1
Asian Scientist Magazine 1

Event Lens

What the news is about

Classified themes
Market update 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-2 of 2